Exposure to Moderate Glycosuria Induces Virulence of Group B Streptococcus.
John. Preeti P PP; Baker. Brady C BC; Paudel. Santosh S; Nassour. Lauren L; Cagle. Hayden H; Kulkarni. Ritwij R
Key Findings
- Moderate glycosuria (â300âŻmg/dL glucose in urine) significantly boosts GBS growth and kidney bacterial load in mice.
- Glycosuria enhances GBS adherence to bladder cells and resistance to the antimicrobial peptide LLâ37 via upâregulation of the dltA gene.
- Exposure to glucose increases expression of GBS virulence genes, including fimbrial (PI2a) and toxinâproducing genes.
Practical Outcomes
- Maintain normal blood glucose levels and avoid persistent glycosuria to lower the risk of aggressive urinary infections. Monitoring urine glucose, especially for diabetics or highâsugar diets, can be a simple preventive step. No direct LLâ37 supplementation guidance emerges from this work.
Summary
The study shows that having moderate sugar in your urine (like what can happen with high blood sugar) makes a common bacteria, Group B Strep, grow faster and become more aggressive, increasing the chance of a urinary tract infection. It also makes the bacteria better at resisting the bodyâs natural antimicrobial peptide LLâ37. For people interested in health optimization, this suggests that keeping blood sugar and urine glucose low could help reduce infection risk.
Abstract
To explore whether glycosuria induces virulence of uropathogens, in turn facilitating urinary tract infection (UTI), we exposed group B Streptococcus (GBS) strain 10/84 to human urine plain or with 300 mg/dL glucose (mimicking moderate glycosuria). Exposure to moderate glycosuria significantly augmented bacterial growth, kidney bacterial burden in a mouse model of ascending UTI, and virulence characteristics and expression of corresponding genes. Exposure to glycosuria increased GBS adherence to human bladder epithelial cell line and expression of corresponding PI2a fimbrial gene, antimicrobial peptide LL-37 resistance and bacterial surface charge modulating dltA, and GBS hemolytic ability and expression of genes encoding pore-forming toxins.
Study Information
pubmed
2021
2021-03-03T00:00:00.000Z
10.1093/infdis/jiaa443
14
15